Intrinsic Value of S&P & Nasdaq Contact Us

MusclePharm Corporation MSLP OTC

Other OTC • Consumer Defensive • Packaged Foods • US • USD

SharesGrow Score
11/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

MusclePharm Corporation (MSLP) is a Packaged Foods company in the Consumer Defensive sector, currently trading at $0.00. It has a SharesGrow Score of 11/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Financials: revenue is $50M, -17%/yr average growth. Net income is $13M (loss), growing at -154.5%/yr. Net profit margin is -25.7% (negative). Gross margin is 10.7% (-10.2 pp trend).

Balance sheet: total debt is $11M with negative equity of -$32M — this means total liabilities exceed total assets. This is a warning sign that may indicate accumulated losses, aggressive share buybacks, heavy debt financing, or aggressive dividend payouts. Companies like McDonald's and Starbucks also carry negative equity due to buybacks and dividends, but investors should assess whether the business generates sufficient cash flow to service its debt and sustain payouts. Current ratio is 0.27 (tight liquidity). Debt-to-assets is 95.5%. Total assets: $11M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 15/100 (Fail), Past 25/100 (Fail), Health 0/100 (Fail), Moat 7/100 (Fail), Future ?/100 (Fail), Income 10/100 (Fail).

MSLP SharesGrow Score Overview

14/100
SharesGrow Score
Weak fundamentals
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 15/100
Financials — average growth
PAST 25/100
strong — trend
HEALTH 0/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 7/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Stock Chart & Stats

Market Data
52-Week Range2.0E-4-0.59
Volume1K
Avg Volume (30D)6.1K
Beta (1Y)-0.05
Share Statistics
EPS (TTM)-0.31
Shares Outstanding$41.17M
IPO Date2010-04-27
Employees21
CEORyan Charles Drexler
Financial Highlights & Ratios
Revenue (TTM)$50.04M
Gross Profit$5.37M
EBITDA$-8.91M
Net Income$-12.88M
Operating Income$-7.4M
Total Cash$1.22M
Total Debt$10.71M
Net Debt$9.48M
Total Assets$11.21M
Price / Earnings (P/E)-0
Analyst Forecast
Company Info
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINUS6273352012

Price Chart

MSLP
MusclePharm Corporation  ·  Other OTC
Consumer Defensive • Packaged Foods
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message